image description

Tag: lupus research alliance

Lupus Research Alliance Prompted Stelara® Study for Lupus

Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. Read More

Pour for a cure

Join us at a private home in beautiful Santa Rosa hill country, decked out in your best diamonds and denim, for the inaugural Pour for a Cure – Taste Wine, Fight Lupus event. Your support will help patients locally as well fund important research towards a cure. September 9, 2017 12 pm – three-course VIP […] Read More

Breaking Through Gala

Please join us for a breakthrough evening celebrating the power of science. Monday, November 20, 2017 6:30 PM – Cocktails 7:30 PM – Dinner Ziegfeld Ballroom 141 West 54th Street, New York City HONORING Steve Burke, CEO, NBCUniversal DISTINGUISHED SERVICE AWARD Margaret G. Dowd, Immediate Past Co-President and CEO, Lupus Research Alliance HOST Seth Myers, […] Read More

2017 Novel Research Grants – Meet the Awardees

July 28, 2017. The Lupus Research Alliance is delighted to announce the recipients of our 2017 Novel Research Grants. These ten grantees continue a commitment to bold and innovative research that aims to discover safe, effective treatments and a cure for lupus. Mridu Acharya, PhD Benaroya Research Institute at Virginia Mason Dr. Acharya is investigating the […] Read More

Willie Colon Tees-Off for Lupus at Golf Outing Benefit

Fore! The Third Annual Willie Colon Golf Outing benefiting the Lupus Research Alliance and the Jean Davis Research Grant raised thousands in crucial funds for lupus research programs — while increasing awareness of the disease. Held at the Somerset Hill Country Club in Bernardsville, NJ, the Outing is the premier golf event in the New […] Read More

Dr. Gerald Nepom Bringing Expertise and a Fresh Perspective

The future of the Lupus Research Alliance is bright with Gerald Nepom, MD, PhD in the critical role of Co-Chair of our Scientific Advisory Board. Over the past three decades, his work has focused on the underlying principles of autoimmunity, biomarkers, and therapy for autoimmune diseases. In the 1980s, Dr. Nepom played a major role […] Read More

Make Your Voice Heard on Lupus Drug Development

The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be part of a history-making project that includes a meeting called Lupus: Patient Voices on September 25 in the Washington, D.C. area. This very important effort is a tremendous opportunity for individuals with lupus to contribute to lupus drug development […] Read More

President Signs Bill that Advances Lupus Research and Care

May 5, 2017. NEW YORK, NY. A bipartisan spending bill for Fiscal 2017 that includes key provisions the Lupus Research Alliance and lupus advocates across the country have fought for was signed into law today. The bill establishes for the first time an annual $5 million lupus medical research program at the Department of Defense […] Read More

Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market, today announced top-line results from its Phase IIb AURA-LV (AURA) study in lupus nephritis (LN). At 48 weeks, the trial met the complete and partial remission (“CR”/ “PR”) endpoints, demonstrating statistically significantly greater CR […] Read More